Neonates were monitored with a cerebral oximeter before, during, and after cannulation for ECMO to determine the direct effects of ligation of the right internal jugular vein and right carotid artery ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio A higher likely risk for mortality in ...

To describe the use of double-lumen venovenous (VVDL) extracorporeal membrane oxygenation (ECMO) with cephalic draining cannula (VVDL+V) as a primary approach for all neonatal respiratory diagnoses ...

Please provide your email address to receive an email when new articles are posted on . Odds for survival on ECMO to transplant went down if the patient had an older age at listing. Survival did not ...

January 13, 2010 (Miami, Florida) — Carotid artery (CA) cannulation for veno-arterial extracorporeal membrane oxygenation (ECMO) is associated with a higher risk for central nervous system (CNS) ...

LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned ...

Breathing. That critical inhale/exhale operation of the lungs is something we often take for granted — until something goes wrong and respiratory problems result. The Center for Acute Respiratory ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window HONOLULU -- In ...

Extracorporeal membrane oxygenation (ECMO) is a method of providing lung and heart support to patients with inadequate blood perfusion in the body, or gas exchange in the lungs. Blood is pumped from ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window TORONTO -- Kids ...

Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, ...